➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Colorcon
AstraZeneca
McKinsey
Merck

Last Updated: January 17, 2021

DrugPatentWatch Database Preview

Novast Labs Ltd Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for NOVAST LABS LTD, and what generic and branded alternatives to NOVAST LABS LTD drugs are available?

NOVAST LABS LTD has nine approved drugs.

There are two tentative approvals on NOVAST LABS LTD drugs.

Summary for Novast Labs Ltd
US Patents:0
Tradenames:9
Ingredients:4
NDAs:9

Drugs and US Patents for Novast Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs Ltd DASETTA 1/35 ethinyl estradiol; norethindrone TABLET;ORAL-28 090948-001 Dec 22, 2011 AB RX No No   Start Trial   Start Trial
Novast Labs Ltd WERA ethinyl estradiol; norethindrone TABLET;ORAL-28 091204-001 Mar 27, 2012 AB RX No Yes   Start Trial   Start Trial
Novast Labs Ltd PHILITH ethinyl estradiol; norethindrone TABLET;ORAL-28 090947-001 Dec 22, 2011 AB RX No No   Start Trial   Start Trial
Novast Labs Ltd FALMINA ethinyl estradiol; levonorgestrel TABLET;ORAL-28 090721-001 Mar 28, 2012 AB1 RX No No   Start Trial   Start Trial
Novast Labs Ltd DASETTA 7/7/7 ethinyl estradiol; norethindrone TABLET;ORAL-28 090946-001 Dec 22, 2011 AB RX No Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Moodys
McKinsey
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.